Skip to search formSkip to main contentSkip to account menu

skin toxicity

Known as: skin toxicities, toxicity skin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Generic docetaxel chemotherapy induced skin toxicities in breast cancer patient
Female patient, 52 years old, three months after mastectomy due to breast cancer was subjected to chemotherapy with docetaxel… 
2015
2015
Analysis of sebum lipid composition and the development of acneiform rash before and after administration of egfr inhibitor.
Treatment with an epidermal growth factor receptor inhibitor (egfri) in patients having non-small-cell lung cancer can cause… 
2015
2015
Association of EGFR CA simple sequence repeat 1 (CA-SSR1) variant with cetuximab (cet)-induced skin toxicity (ST) in Japanese metastatic colorectal cancer (mCRC) patients (pts) with overexpressed…
582 Background: Associations of EGFR gene copy number (GCN) and EGFR CA-SSR1 polymorphism with clinical outcome still remain… 
2013
2013
Correlation of skin toxicity and hypertension with clinical benefit in advanced hepatocellular carcinoma patients treated with sorafenib.
OBJECTIVE The purpose of this study was to identify the correlation of skin toxicity and hypertension with clinical benefit in… 
2012
2012
Abstract 4297: Racial/ethnic disparities in breast cancer radiosensitivity
Purpose: To evaluate radiotherapy (RT)-related skin toxicity and its relationship to quality of life (QOL) outcomes in a tri… 
2011
2011
Digital image analysis of facial erythema over time in persons with varied skin pigmentation
Background/purpose: Selected chemotherapeutic agents used for the treatment of cancer are known to cause skin toxicities. One… 
2011
2011
Pre-emptive skin toxicity treatment for anti-EGFR drugs: Evaluation of efficacy of skin moisturizers and limecicline-A phase II study.
e19542 Background: Anti-EGFR target therapies like erlotinib (E) for metastatic lung cancer (mLC) and cetuximab (C)/panitumumab… 
2010
2010
Randomized, open-label, phase III study of panitumumab (pmab) with FOLFOX4 versus FOLFOX4 alone as first-line treatment (tx) for metastatic colorectal cancer (mCRC): Efficacy by skin toxicity (ST).
3528^ Background: Pmab is a fully human antiepidermal growth factor receptor (EGFR) monoclonal antibody approved as monotherapy… 
2009
2009
Final STEPP results of prophylacatic versus reactive skin toxicity (ST) treatment (tx) for panitumumab (pmab)-related ST in patients (pts) with metastatic colorectal cancer (mCRC).
CRA4027 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings… 
Highly Cited
2006
Highly Cited
2006
Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients
Summaryp53 and p21 play an important role in G1/S checkpoint control in response to ionizing radiation. Yet the genetic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)